Showing 1 - 4 results of 4 for search 'John A Glaspy', query time: 0.03s Refine Results
  1. 1
    Pharmacodynamic Characterization of the Efficacy Signals Due to Selective BRAF Inhibition with PLX4032 in Malignant Melanoma

    Pharmacodynamic Characterization of the Efficacy Signals Due to Selective BRAF Inhibition with PLX4032 in Malignant Melanoma by William D. Tap, Ke-Wei Gong, Judy Daring, Yiou Tseng, Charles Ginther, Giovanni Pauletti, John A. Glaspy, Richard Essner, Gideon Bollag, Peter Hirth, Chao Zhang, Dennis J. Slamon

    Published 2010-08-01
    Get full text
    Article
  2. 2
    Multiplexed imaging reveals an IFN-γ-driven inflammatory state in nivolumab-associated gastritis

    Multiplexed imaging reveals an IFN-γ-driven inflammatory state in nivolumab-associated gastritis by Selena Ferrian, Candace C. Liu, Erin F. McCaffrey, Rashmi Kumar, Theodore S. Nowicki, David W. Dawson, Alex Baranski, John A. Glaspy, Antoni Ribas, Sean C. Bendall, Michael Angelo

    Published 2021-10-01
    Get full text
    Article
  3. 3
    Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway.

    Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway. by Mohammad Atefi, Erika von Euw, Narsis Attar, Charles Ng, Connie Chu, Deliang Guo, Ramin Nazarian, Bartosz Chmielowski, John A Glaspy, Begonya Comin-Anduix, Paul S Mischel, Roger S Lo, Antoni Ribas

    Published 2011-01-01
    Get full text
    Article
  4. 4
    A careful reassessment of anthracycline use in curable breast cancer

    A careful reassessment of anthracycline use in curable breast cancer by Sara Alsterlind Hurvitz, Nicholas P. McAndrew, Aditya Bardia, Michael F. Press, Mark Pegram, John P. Crown, Peter A. Fasching, Bent Ejlertsen, Eric H. Yang, John A. Glaspy, Dennis J. Slamon

    Published 2021-10-01
    Get full text
    Article

Search Tools: